Healthcare, Pharma & Life Sciences

Hamburg Approves EU-Wide Tender for New Asklepios Altona Hospital

Image
Hamburg Approves EU-Wide Tender for New Asklepios Altona Hospital

Hamburg – September 11, 2026 -- Hamburg's Senate has approved the procedural framework for a new Asklepios Klinik Altona, clearing the way for a Europe-wide tender to build a 600-bed hospital serving more than 280,000 residents in western Hamburg.

Senate clears path for continent-wide procurement process

The city's Social Affairs Authority and Asklepios have agreed on key parameters covering planning and construction awards, project financing, supporting infrastructure and land provision. The Hamburg parliament (Bürgerschaft) will decide on final construction and equipment costs once tender results are in, with a vote expected by the end of 2027.

GCCL Expands Asia-Pacific Reach as Platinum Sponsor at ABP 2026

Image
GCCL Expands Asia-Pacific Reach as Platinum Sponsor at ABP 2026

Yongin, South Korea – September 11, 2026 -- GCCL (Global Clinical Central Lab), a South Korea-based clinical trial sample analysis provider, sponsored the Asia Bio Partnering Forum 2026 (ABP 2026) as a Platinum Sponsor, using the Singapore event to pursue expansion of its assay development and clinical sample analysis services across the Asia-Pacific region.

GCCL held partnering meetings with drug developers across mRNA, radiopharmaceutical and antibody therapy segments

The forum, held in Singapore from August 31 to September 2, drew approximately 650 pharmaceutical and biotechnology industry professionals, investors and life sciences stakeholders, generating roughly 2,500 one-on-one partnering meetings. GCCL engaged drug developers working across mRNA and nucleic acid therapeutics, radiopharmaceuticals and antibody-based therapies to assess evolving analytical requirements in global clinical development.

Highlands Community Services Featured on PBS Series on Rural Care

Image
Highlands Community Services Featured on PBS Series on Rural Care

Los Angeles – – September 11, 2026 -- Highlands Community Services, a regional behavioral health provider in Southwest Virginia, will be featured in an upcoming segment of the Public Television series "All Access hosted by Andy Garcia," spotlighting trauma-informed care models designed to close service gaps in rural mental health and addiction treatment.

Program targets justice-system diversion for behavioral health crises

The segment examines how sparse rural infrastructure often forces law enforcement officers to act as primary responders during acute psychiatric emergencies, a pattern that drives unnecessary arrests and strains public resources. Highlands Community Services details how direct referral pathways and trauma-informed training for first responders, educators and local agencies redirect individuals from the justice system into clinical treatment settings.

Insightec Hits 10,000 EMEA Patients Treated With Focused Ultrasound

Image
Insightec Hits 10,000 EMEA Patients Treated With Focused Ultrasound

Haifa/Frankfurt – September 11, 2026 -- Insightec has treated 10,000 patients across Europe, the Middle East and Africa with its Exablate Neuro platform for essential tremor and Parkinson's disease, a figure that has more than doubled over the past three years. The incisionless MR-guided focused ultrasound (MRgFUS) therapy is now available at more than 62 treatment centers in 20 countries across the region, part of a global network exceeding 30,000 patients treated at 226 centers worldwide.

Treatment volumes double in three years as adoption accelerates

The EMEA milestone caps a decade of expansion for focused ultrasound in the region, with hospitals increasingly offering the incisionless approach to patients whose only prior options were medication or invasive surgery. Growth spans both essential tremor and Parkinson's disease indications, according to Jake Ghannam, Executive Vice President and Chief Commercial Officer at Insightec.

Intuitive Wins CE Mark for da Vinci 5 Force Feedback in Europe

Image
Intuitive Wins CE Mark for da Vinci 5 Force Feedback in Europe

Freiburg – – September 11, 2026 -- Intuitive Surgical has secured CE marking for Force Feedback instruments on its da Vinci 5 surgical system, clearing the technology for use across the European market alongside more than 100 additional system updates.

Force Feedback lets surgeons feel tissue resistance in real time

The instruments capture pressure, traction and lateral forces roughly 1,000 times per second, relaying them directly through the hand controllers on the da Vinci 5 console. A real-time force gauge, resembling a speedometer, displays the intensity of force applied to tissue during a procedure. Post-operatively, surgeons can review force data through Case Insights in the MyIntuitive+ platform to refine technique and reduce variability between cases.

PeproMene's BAFF-R CAR-T Hits 80% Complete Remission in Lancet Study

Image
PeproMene's BAFF-R CAR-T Hits 80% Complete Remission in Lancet Study

Irvine, California – September 11, 2026 -- PeproMene Bio, Inc. reported that seven of nine patients (80%) treated with its BAFF-R-targeted CAR-T therapy PMB-CT01 achieved complete remission in a Phase 1 trial, with results now published in The Lancet.

All complete responses remained relapse-free at data cutoff, with the longest sustained remission reaching 35 months

Four of six patients who had previously progressed after conventional CD19-directed CAR-T therapy also achieved complete response under the new BAFF-R approach, described in the study as "CAR after CAR" treatment. No relapses were observed among any of the seven complete responders as of the data cutoff.

Capricor Sued Over Deramiocel Data After 64.5% Stock Collapse

Image
Capricor Sued Over Deramiocel Data After 64.5% Stock Collapse

New York – September 11, 2026 -- Capricor Therapeutics, Inc. (NASDAQ:CAPR) faces a securities fraud class action after its shares plunged 64.5% following disclosures about alleged undisclosed changes to clinical trial statistics underlying its Duchenne muscular dystrophy therapy application.

ZDF Charity Quiz Raises 4.6 Million Euros for German Cancer Aid

Image
ZDF Charity Quiz Raises 4.6 Million Euros for German Cancer Aid

Berlin – September 11, 2026 -- German Cancer Aid (Deutsche Krebshilfe) collected roughly 4.6 million euros in donations during a televised charity quiz special broadcast on public broadcaster ZDF.

Celebrity contestants earn 80,000 euros in quiz duels against subject experts

Actors Moritz Bleibtreu and Henning Baum, alongside model Franziska Knuppe, competed on "Der Quiz-Champion - Das Spenden-Special," hosted by Johannes B. Kerner, against five specialists: Anna Thalbach, Johann Lafer, Felix Neureuther, Elton and Katrin Bauerfeind. The three celebrities' combined quiz performance generated 80,000 euros for German Cancer Aid.

Epicyt Pharma's BAFA Cuts Urinary Calcium Loss in Bypass Patients

Gothenburg – – September 11, 2026 -- Epicyt Pharma AB reported positive topline results from a Phase 1/2a first-in-human study of its oral drug candidate BAFA, showing a statistically significant reduction in urinary calcium excretion in patients who underwent Roux-en-Y gastric bypass (RYGB) surgery. The Gothenburg-based clinical-stage biopharmaceutical company said the trial, completed in March 2026, also recorded improvements in key biomarkers of calcium homeostasis, consistent with enhanced intestinal calcium uptake.

BAFA targets a market of 3.5 million patients across the EU and US

Epicyt estimates that approximately 3.5 million people in the EU and US currently live with impaired calcium homeostasis following bariatric surgery, with roughly 250,000 new patients added annually. RYGB is widely used to treat severe obesity but frequently impairs calcium uptake, raising the risk of secondary hyperparathyroidism, reduced bone density and fractures.

GCCL Sponsors ABP 2026 to Expand Asia-Pacific Clinical Lab Services

Image
GCCL Sponsors ABP 2026 to Expand Asia-Pacific Clinical Lab Services

Yongin, South Korea – September 11, 2026 -- GCCL (Global Clinical Central Lab), a South Korea-based clinical trial sample analysis provider, served as a Platinum Sponsor at the Asia Bio Partnering Forum 2026 (ABP 2026) in Singapore, held from August 31 to September 2, as it pursued expansion of its assay development and sample analysis services across the Asia-Pacific region.

ABP 2026 drew 650 industry professionals and 2,500 one-on-one partnering meetings

The forum brought together approximately 650 pharmaceutical and biotechnology executives, investors and life sciences stakeholders, with roughly 2,500 one-on-one partnering meetings held over three days. GCCL used the event to hold discussions with drug developers, contract research organizations (CROs) and regional stakeholders from Korea, China, Japan, Singapore, Vietnam and Europe.